Abbott Laboratories (ABT)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
114.73+0.01 (+0.01%)
At close: 4:02PM EST
| Previous close | 114.72 |
| Open | 114.25 |
| Bid | 115.00 x 900 |
| Ask | 115.20 x 800 |
| Day's range | 113.79 - 115.12 |
| 52-week range | 61.61 - 115.40 |
| Volume | 3,952,932 |
| Avg. volume | 4,884,911 |
| Market cap | 203.343B |
| Beta (5Y monthly) | 0.83 |
| PE ratio (TTM) | 60.67 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.80 (1.57%) |
| Ex-dividend date | 14 Jan 2021 |
| 1y target est | N/A |
- Motley Fool
2 Stocks I'll Hold Forever
As a major pharma company, AbbVie (NYSE: ABBV) delivers for its investors by developing and commercializing new drugs, like its best-selling arthritis treatment Humira. There's two reasons AbbVie is worth holding forever: its skill with drug development, and its generous dividend. Like many other pharma companies, AbbVie maximizes the revenue that it gets from each of its drug development projects by investigating their usefulness for multiple illnesses.
- Zacks
Demand for COVID-19 Tests to Drive Abbott (ABT) Q4 Earnings
Within EPD, Abbott (ABT) is expected to have witnessed visible signs of rebound through Q4.
- Zacks
The Zacks Analyst Blog Highlights: Quest Diagnostics, Abbott, Becton, Dickinson and Co, Quidel and Hologic
The Zacks Analyst Blog Highlights: Quest Diagnostics, Abbott, Becton, Dickinson and Co, Quidel and Hologic
© 2021 Verizon Media. All rights reserved.
